Hairy root (HR) cultures derived from Agrobacterium rhizogenes (A. rhizogenes) transformation of plant tissues are an advantageous biotechnological manufacturing platform due to the accumulation of recombinant proteins in an otherwise largely protein free culture medium. In this context, HRs descending from transgenic Nicotiana tabacum (N. tabacum) plants were successfully used for the production of several functional mAbs with plant-type glycans. Here, we expressed the tumour-targeting mAb H10 in HRs obtained either by infecting a transgenic N. tabacum line expressing H10 with A. rhizogenes or a glyco-engineered N. benthamiana line (?XTFT) with recombinant A. rhizogenes carrying mAb H10 heavy and light chain cDNAs. Selected HR clones derived from both plants accumulated mAb H10 in the culture medium with similar yields (2-3 mg/L). N-glycosylation profiles of antibodies purified from HR supernatant revealed the presence of plant-typical complex structures for N. tabacum-derived mAbH10 and of GnGn structures lacking xylose and fucose for the ?XTFT-derived counterpart. Both antibody glyco-formats exhibited comparable antigen binding activities. Collectively, these data demonstrate that the co-infection of ?XTFT N. benthamiana with recombinant A. rhizogenes is an efficient procedure for the generation of stable HR cultures expressing the tumour-targeting mAb H10 with a human-compatible glycosylation profile, thus representing an important step towards the exploitation of root cultures for the production of 'next generation' human therapeutic antibodies.

Production of a tumour-targeting antibody with a human-compatible glycosylation profile in N. benthamiana hairy root cultures.

Scaloni A;Salzano AM;
2016

Abstract

Hairy root (HR) cultures derived from Agrobacterium rhizogenes (A. rhizogenes) transformation of plant tissues are an advantageous biotechnological manufacturing platform due to the accumulation of recombinant proteins in an otherwise largely protein free culture medium. In this context, HRs descending from transgenic Nicotiana tabacum (N. tabacum) plants were successfully used for the production of several functional mAbs with plant-type glycans. Here, we expressed the tumour-targeting mAb H10 in HRs obtained either by infecting a transgenic N. tabacum line expressing H10 with A. rhizogenes or a glyco-engineered N. benthamiana line (?XTFT) with recombinant A. rhizogenes carrying mAb H10 heavy and light chain cDNAs. Selected HR clones derived from both plants accumulated mAb H10 in the culture medium with similar yields (2-3 mg/L). N-glycosylation profiles of antibodies purified from HR supernatant revealed the presence of plant-typical complex structures for N. tabacum-derived mAbH10 and of GnGn structures lacking xylose and fucose for the ?XTFT-derived counterpart. Both antibody glyco-formats exhibited comparable antigen binding activities. Collectively, these data demonstrate that the co-infection of ?XTFT N. benthamiana with recombinant A. rhizogenes is an efficient procedure for the generation of stable HR cultures expressing the tumour-targeting mAb H10 with a human-compatible glycosylation profile, thus representing an important step towards the exploitation of root cultures for the production of 'next generation' human therapeutic antibodies.
2016
Istituto per il Sistema Produzione Animale in Ambiente Mediterraneo - ISPAAM
Glycosylation, Hairy roots, Molecular farming, Proteolysis, Rhizosecretion, mAb
File in questo prodotto:
File Dimensione Formato  
prod_355882-doc_119345.pdf

solo utenti autorizzati

Descrizione: Production of a tumor-targeting antibody with a human- compatible glycosylation profile in N. benthamiana hairy root cultures
Tipologia: Versione Editoriale (PDF)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 2.14 MB
Formato Adobe PDF
2.14 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
prod_355882-doc_185699.pdf

accesso aperto

Descrizione: Preprint: Production of a tumor-targeting antibody with a human- compatible glycosylation profile in N. benthamiana hairy root cultures
Tipologia: Versione Editoriale (PDF)
Licenza: Nessuna licenza dichiarata (non attribuibile a prodotti successivi al 2023)
Dimensione 1.8 MB
Formato Adobe PDF
1.8 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/324720
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact